Home   Registration Form   Contact us     فارسی
Congress Programبرنامه کنگره

Day 1 – Saturday, October 28, 2017

 

TIME

PROGRAMME

SPEAKER

7:30-8:00

The Recitation of the Holy Quran , National Anthem of the Islamic Republic of Iran

 

8:00-8:30

Welcome & Opening Remarks

Ardeshir Ghavamzadeh,  Kamran Alimoghaddam

8:30-10:10

Plenary 1: APBMT/ WBMT Joint Session: Transplantation reports in the Asian pacific region & the progress of BMT in the world and Asian pacific region

Chairpersons: Ardeshir Ghavamzadeh, Shinichiro Okamoto

8:30-8:45

The progress of BMT in the Islamic Republic of Iran

Ardeshir Ghavamzadeh

8:45-9:00

The report of transplantation in all 15 BMT centers of Iran in the last five years

Abbas Hajifathali, Mani Ramzi, Mehrdad Payandeh

9:00-9:20

The current status and future challenges of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT)

Shinichiro Okamoto

9:20-9:30

The history, current status and future trends of WBMT

Yoshihisa Kodera

9:30-9:40

The report of transplantation in China in five recent years

He Huang

9:40-9:50

The advance of HSCT after the enforcement of "The Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations" in Japan

Yoshihisa Kodera

9:50-10:00

Outcome of autologous hematopoietic stem cell transplants for multiple myeloma in a single center in Sri Lanka

Lalindra Gooneratne

10:00-10:10

The report of transplantation in Malaysia in five recent years

Ong Tee Chuan

10:10-10:30

Coffee Break

 

10:30-13:00

Plenary 2: Educational session of immunotherapy & gene therapy in the transplantation era: CART-Cell

Chairpersons:  He Huang, François Lefrere

10:30-10:50

The first results of gene therapy in the area of hemoglobinopathies

François Lefrere

10:50-11:10

New and old targets for CART-Cell

Antonia Müller

11:10-11:30

Clinical experience with CD19 CAR for lymphoid malignancies

Kevin Hay

11:30-11:50

Advanced CD19-CART therapy for acute lymphocytic leukemia and B cell Lymphoma/ China Perspective

He Huang

11:50-12:10

Toxicity of CART therapy

Kevin Hay

12:10-12:30

Panel Discussion

He Huang, Kevin Hay, Antonia Muller, François Lefrere

12:30-14:00

Prayer & Lunch Break

 

14:00-16:00

Plenary 3: Haploidentical and other related transplantations/ MRD in the post transplantation Era

Chairpersons: Raymond Leonard Powles, Mohamed Sorror

14:00-14:20

Haploidentical hematological stem cell transplantation as a front line therapy for adult Acute Lymphocytic Leukemia

He Huang

14:20-14:40

A comparison between gene therapy and haploidentical stem cell transplantation for SCID syndrome

François Lefrere

14:40-15:00

Incorporating patient health in the decision-making about the treatment of Acute Myeloid Leukemia

Mohamed Sorror

15:00-15:20

MRD in Philadelphia Positive ALL patients post-transplant

Koichi Miyamura

15:20-15:40

Place of Stem Cell Transplants for accidental irradiation incidents

Raymond Leonard Powles

15:40-16:00

Panel Discussion

Mohamed Sorror, He Huang, Koichi Miyamura, Raymond Leonard Powles

16:00-16:30

Coffee Break

 

16:00-17:30

Poster Presentation

 

 

Day 2 - Sunday, October 29, 2017

 

TIME

PROGRAMME

SPEAKER

8:30-10:00

Plenary 4: Transplantation in Pediatrics & the quality of HSCT

Chairpersons: Amir Ali Hamidieh, Amir Abbas Hedayati Asl

8:30-8:50

NK Cell-Derived Exosomes enhance NKs anti-Neuroblastoma activity in a preclinical study: Future NK cell therapy for relapsed Neuroblastoma after HSCT

Amir Ali Hamidieh

8:50-9:10

Transplantation outcome in Pediatric Philadelphia positive ALL patients

Amir Abbas Hedayati Asl

9:10-9:25

Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Leukocyte Adhesion Deficiency Type I: A Single Center Experience

Tahereh Rostami

9:25-9:45

Insurance approval of mesenchymal stem cell therapy for steroid refractory acute GVHD in Japan

Koichi Miyamura

9:45-10:00

Panel Discussion

Amir Ali Hamidieh, Amir Abbas Hedayati Asl, Tahereh Rostami, Koichi Miyamura

10:00-10:30

Coffee Break

 

10:30-13:00

Plenary 5: Transplantation in older and non-malignant patients/ MRD in the Transplantation Era

Chairpersons: Mehrdad Payandeh, Rainer Storb

10:30-10:50

Transplantation in older patients

Rainer Storb

10:50-11:10

Comorbidities and age in Allogeneic Hematopoietic Cell Transplantation

Mohamed Sorror

11:10-11:30

Transplantation for patients with non-malignant blood disorders

Rainer Storb

11:30-11:50

Persistent challenge of the detection of minimal residual disease

Koichi Miyamura

11:50-12:10

Transplantation in patients with comorbid diseases

Mehrdad Payandeh

12:10-12:30

Panel Discussion

Rainer Storb, Mohamed Sorror, Mehrdad Payandeh, Koichi Miyamura,

12:30-14:00

Prayer & Lunch Break

 

14:00-16:00

Plenary 6: Pre and Post transplantation treatment:{Allogeneic, Autologous, NK cell and DLI}

Chairpersons: Riccardo Saccaradi, Mahshid Mehdizadeh, Mazyar Shadman

14:00-14:20

Prophylactic and pre-emptive DLI

Hans Jochem Kolb

14:20-14:40

Transplant for double or triple hit lymphoma and their management

Mazyar Shadman

14:40-15:00

HSCT for Multiple Sclerosis

Riccardo Saccaradi

15:00-15:20

Post-transplant maintenance in lymphoid malignancies

Mazyar Shadman

15:20-15:40

International accreditation and quality of HSCT: the JACIE experience

Riccardo Saccaradi

15:40-16:00

Panel Discussion

Mazyar Shadman, Hans Jochem Kolb, Riccardo Saccaradi, Mahshid Mehdizadeh

16:00-16:30

Coffee Break

 

16:00-17:30

Poster Presentation

 

 

Day 3 – Monday, October 30, 2017

 

TIME

PROGRAMME

SPEAKER

8:30-10:00

Plenary 7: An educational session of cell therapy and regenerative medicine, GVHD and transplantation in non-malignant diseases

Chairpersons: Kamran Alimoghaddam, Rainer Storb, Nicolas Kröger

8:30-8:45

Graft-versus-host disease and graft-versus-tumor effects

Rainer Storb

8:45-9:00

Chronic GVHD and immune function post allo-HSCT

Antonia Müller

9:00-9:15

Treatment options for steroid refractory GVHD

Nicolas Kröger

9:15-9:30

Daratumumab in conjunction with ABMT (Cancer Centre London Experience)

Raymond Leonard Powles

9:30-9:45

Role of ATG in preventing GVHD after allogeneic SCT

Nicolas Kröger

9:45-10:00

Panel Discussion

Nicolas Kröger, Rainer Storb, Raymond Leonard Powles, Antonia Muller

10:00-10:30

Coffee Break

 

10:30-13:00

Oral Presentations from submitted abstracts

Chairpersons: Seyed Asadollah Mousavi, Mohamad Vaezi, Hossein Kamranzadeh

10:30-10:45

Autologous cord blood transplantation in children with Acquired Severe Aplastic Anemia

Sun Yuan

10:45-11:00

Successful treatment with granulocyte transfusion and early neutrophil engraftment in allogeneic transplant patients with febrile neutropenia

Ali Unal

11:00-11:15

Multiple Myeloma: Allogeneic or Autologous Hematopoietic Stem Cell Transplantation

Sahar Tavakoli

11:15-11:35

Pedigree analysis: a tool for finding matched donors in patient's’ second and third degrees relatives

Mohammad Reza Ostadali

11:35-11:50

Evaluation of HLA-identical sibling allogenic peripheral blood stem cell transplantation for acute myelogenous leukemia at BTH, Vietnam

Van Man Huynh

11:50-12:05

Outcomes of co-transplantation of mesenchymal and hematopoietic stem cells compared to hematopoietic stem cell transplantation alone in beta thalassemia patients

Hossein Ranjbar

12:05-12:15

Hepatogenic differentiation of IPS cells on an aligned Polyether sulfone compared to random nanofibers

Maryam Kabir Salmani

12:15-12:25

Mild hypotxia and bone marrow mesenchymal stem cells enhance the expansion and homing of human cord blood CD34+ stem cells

Fatemeh Mohammadali

12:25-12:35

Expansion of umbilical cord blood hematopoietic stem cells on biocompatible nanofiber scaffolds as a co-culture with bone marrow derived mesenchymal stem cells

Majeed Mokhtari

12:35-13:00

Questions & Answers

 


       -       -       -       -       -       -       -       -       -       -
Gallery
Welcome Massage

We are delighted to welcome you to the congress of the APBMT inTehran, Iran, 2017.

It is our great pleasure to invite you to participate in the next APBMT conference which will be held in Tehran, Iran 28-30 oct 2017 . The APBMT conference is a great opportunity to bring together scholars from the Asia pacific region to communicate and exchange ideas in order to improve the outcome of HSCT.We are honored to have invited well-known and esteemed scientists whose work, research and efforts need no introduction.Now I would like to draw your attention to a brief overview over beauties of Iran and events organized successfully by Iranian society of stem cell transplant. Our research institute actively involved in arranging important national and international conferences in hematology oncology and stem cell transplantation such as APBMT conference which was held in Tehran in 2004 and APCC conference in 2007. We are looking forward to meeting you in Tehran

Prof. Ardeshir Ghavamzadeh
President of the Congress

 

Login

Username :
Password :
  Forgot Password!
Registration Abstract Submission Guideline Congress workshops list Congress Introduction
About Iran
News
Newsletter
Sponsors
Please enter your email to receive newsletter
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Visits statistics
Contact Us
Calendar
Today 60
Month 5737
Total Visits 53115
Address: HORC-SCT Kargar Ave.Shariati Hospital, Tehran Iran
Tel: +98-21-8490 2662 +98-21-8490 2635
Email: info@apbmt2017.org